<!-- 顶部横幅 Banner（带渐变遮罩 + 标题） -->
<div style="
  width: 100%;
  height: 330px;
  background: 
    linear-gradient(rgba(0,0,0,0.40), rgba(0,0,0,0.40)),
    url('BLOOD-AND-MARROW-STEM-CELL-TRANSPLANTATION.jpg') center center / cover no-repeat;
  display: flex;
  flex-direction: column;
  align-items: center;
  justify-content: center;
  color: white;
  text-align: center;
  padding: 20px;
">

  <h1 style="font-size: 42px; font-weight: 800; margin: 0;">
    Xiao-Hua Luo's Lab
  </h1>

  <p style="font-size: 20px; font-weight: 400; margin-top: 12px;">
    Precision Immunology · Virus-driven Immune Remodeling · HSCT · CAR-T
  </p>
</div>

<!-- 主内容区域 -->
<div style="
  max-width: 900px;
  margin: 40px auto;
  background: white;
  padding: 36px;
  border-radius: 12px;
  box-shadow: 0 10px 30px rgba(0,0,0,0.15);
">

[Home](/lab) · [Members](/lab/members) · [Projects](/lab/projects) · [Publications](/lab/publications) · [Contact](/lab/contact)

# Welcome

We study virus-driven immune remodeling after HSCT and CAR-T and develop immunotherapies in AML to improve immune recovery and disease control.  
By integrating HSCT, CAR-T, and other immune-based strategies, we aim to advance precision treatment for hematologic malignancies.

</div>
